Page 28 - Contract Development News Today

Get latest articles and stories on Latest News at LatestLY. JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 35 per cent increase in profit after tax at Rs 142 crore in the first quarter ended June 30, 2023. Latest News | JB Pharma Q1 PAT Grows 35 Pc to Rs 142 Cr.

Sigma Mostafa is the chief scientific officer of KBI Biopharma, a development and contract manufacturing organization serving the biopharmaceutical industry.

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £4 million to scale up market-testing of its technology platform Cytomos Dielectric Spectroscopy (CDS).

Concord Biotechs financial landscape has undergone notable shifts, with operational margins stabilising around 40-42% in 2023.

Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred...

/PRNewswire/ -- The bioprocess validation market size to grow by USD 280.93 million between 2022 and 2027, and register a CAGR of 11.39%, according to...

The oncology sector – like most of the healthcare sector – has been struggling post-COVID boom, faltering in the face of a tight financial market reluctant...

BASEL, Switzerland, August 03, 2023 / B3C newswire / -- Celonic Group, a Swiss-based Biologics Contract Development and Manufacturing Organization (CDMO), has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER &am...

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023....

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), today announced its consolidated results for the first quarter (Q1) ended 30th June 2023....